Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1451 to 1500 of 3807 results for treatment

  1. What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?

    is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes? Any explanatory notes(if...

    Research recommendation
    Published
    9 June 2015

  2. Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer (HTG714)

    Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.

    HealthTech guidance
    Published
    2 April 2024
    View recommendations

    Sections for HTG714

  3. Percutaneous tibial nerve stimulation for faecal incontinence (HTG263)

    Evidence-based recommendations on percutaneous tibial nerve stimulation (PTNS) for faecal incontinence. This involves inserting a fine needle into a nerve just above the ankle and passing a mild electric current through the needle to the nerves that control bowel function.

    HealthTech guidance
    Published
    25 May 2011
    View recommendations

    Sections for HTG263

  4. Late access to services and compulsory and intensive treatment:- For people using adult mental health services, what are the personal and demographic factors associated with late access to services and an increased likelihood of compulsory and intensive treatment, and what are the key themes that are associated with poor engagement? This should include an examination of factors that impact on access to services among younger people and older adults.

    Question Late access to services and compulsory and intensive treatment:- For people using adult mental health services, what are the...

    Research recommendation
    Published
    9 June 2015

  5. Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (HTG333)

    Evidence-based recommendations on electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma. This involves injecting a chemotherapy drug into the tumour and using electrical pulses to increase its effect.

    HealthTech guidance
    Published
    26 February 2014
    View recommendations

    Sections for HTG333

  6. 3C Patch for treating diabetic foot ulcers (HTG615)

    Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers.

    HealthTech guidance
    Published
    7 March 2022
    View recommendations

    Sections for HTG615

  7. Selective internal radiation therapy for primary hepatocellular carcinoma (HTG314)

    Evidence-based recommendations on selective internal radiation therapy (SIRT) for primary hepatocellular carcinoma. This involves infusion of microspheres loaded with yttrium-90, which aims to deliver radiation directly into the tumour, minimising the risk of radiation damage to healthy surrounding tissues.

    HealthTech guidance
    Published
    23 July 2013
    View recommendations

    Sections for HTG314

  8. Photodynamic therapy for localised inoperable endobronchial cancer (HTG85)

    Evidence-based recommendations on photodynamic therapy (PDT) for localised inoperable endobronchial cancer (non-small-cell lung cancer). This involves injecting a photosensitising agent into the body that is activated by laser light to destroy the cancerous tissue.

    HealthTech guidance
    Published
    23 November 2005
    View recommendations

    Sections for HTG85

  9. Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy (HTG472)

    Evidence-based recommendations on low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy. This involves applying low-energy lasers to the affected tissue.

    HealthTech guidance
    Published
    23 May 2018
    View recommendations

    Sections for HTG472

  10. Liraglutide for managing overweight and obesity (TA664)

    Evidence-based recommendations on liraglutide (Saxenda) for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity in adults.

    Technology appraisal guidance
    Published
    9 December 2020
    View recommendations

    Sections for TA664

  11. Peripheral arterial disease (QS52)

    This quality standard covers diagnosing and managing lower limb peripheral arterial disease in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    21 January 2014
    View quality statements

    Sections for QS52

  12. Micropressure therapy for refractory Ménière's disease (HTG285)

    Evidence-based recommendations on micropressure therapy for refractory Ménière's disease. This involves inserting a grommet (small tube) through the eardrum into the middle ear and blowing air at low pressure into the inner ear.

    HealthTech guidance
    Published
    26 April 2012
    View recommendations

    Sections for HTG285

  13. Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)

    Summary of the evidence on oritavancin for acute bacterial skin and skin structure infections (ABSSSI) in adults

    Evidence summary
    Published
    11 May 2022

  14. Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment (HTG748)

    Early value assessment (EVA) guidance on digital therapy for chronic tic disorders and Tourette syndrome.

    HealthTech guidance
    Published
    7 May 2025
    View recommendations

    Sections for HTG748

  15. Transcranial magnetic stimulation for auditory hallucinations (HTG555)

    Evidence-based recommendations on transcranial magnetic stimulation for auditory hallucinations. This involves stimulating the brain with pulses of electromagnetic energy.

    HealthTech guidance
    Published
    23 September 2020
    View recommendations

    Sections for HTG555

  16. For which service users who are moderately and severely dependent on alcohol is an assertive community treatment model a clinically and cost-effective intervention compared with standard care?

    moderately and severely dependent on alcohol is an assertive community treatment model a clinically and cost-effective intervention...

    Research recommendation
    Published
    9 June 2015

  17. Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (HTG677)

    Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers.

    HealthTech guidance
    Published
    24 May 2023
    View recommendations

    Sections for HTG677

  18. Focal therapy using cryoablation for localised prostate cancer (HTG284)

    Evidence-based recommendations on focal therapy using cryoablation for localised stage prostate cancer. This involves using freezing (cryotherapy) needles to find and destroy only the cancerous part of the prostate.

    HealthTech guidance
    Published
    26 April 2012
    View recommendations

    Sections for HTG284

  19. Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants (HTG276)

    Evidence-based recommendations on drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants. This involves draining excess CSF from the brain, washing out the blood, and breaking down blood clots using drugs (fibrinolytics).

    HealthTech guidance
    Published
    23 November 2011
    View recommendations

    Sections for HTG276

  20. What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy compared to resection for people with metastatic colorectal cancer in the lung amenable to local treatment?

    people with metastatic colorectal cancer in the lung amenable to local treatment? Any explanatory notes(if applicable) Why the committee...

    Research recommendation
    Published
    10 February 2020

  21. Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)

    Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making

    Evidence summary
    Published
    3 July 2015

  22. News, blogs and podcasts

    2026 First NICE recommended treatment for uncontrolled generalised myasthenia gravis We've recommended a new treatment...

  23. Postural hypotension in adults: fludrocortisone (ESUOM20)

    Summary of the evidence on fludrocortisone for treating postural hypotension in adults to inform local NHS planning and decision-making

    Evidence summary
    Published
    1 October 2013

  24. EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing (HTG296)

    Evidence-based recommendations on EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing.

    HealthTech guidance
    Last updated
    8 October 2019
    View recommendations

    Sections for HTG296

  25. Controlled drugs: safe use and management (NG46)

    This guideline covers systems and processes for using and managing controlled drugs safely in all NHS settings except care homes. It aims to improve working practices to comply with legislation and have robust governance arrangements. It also aims to reduce the safety risks associated with controlled drugs.

    NICE guideline
    Published
    12 April 2016
    View recommendations

    Sections for NG46

  26. NICE considered that there is an important need for head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment with tumour necrosis factor (TNF) alpha inhibitors has been unsuccessful.

    head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment...

    Research recommendation
    Published
    5 October 2015

  27. NICE encourages further research into percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. Further research should include details of patient selection, the duration of patients' symptoms, and a precise account of the technique used for treatment. Outcome measures should include pain relief and quality of life. Long-term follow-up data shouldinclude details of any subsequent procedures.

    encourages further research into percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain....

    Research recommendation
    Published
    15 March 2016

  28. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (HTG645)

    Evidence-based recommendations on extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. This involves placing a device on the skin that delivers short pulses of sound into the shoulder. The aim is to reduce pain and improve shoulder function.

    HealthTech guidance
    Published
    9 November 2022
    View recommendations

    Sections for HTG645

  29. Magnetic resonance therapy for knee osteoarthritis (HTG588)

    Evidence-based recommendations on magnetic resonance therapy for knee osteoarthritis in adults. This involves placing a magnetic resonance device over the knee to stimulate cartilage to heal and relieve the symptoms of osteoarthritis.

    HealthTech guidance
    Published
    25 August 2021
    View recommendations

    Sections for HTG588

  30. Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (AMR2)

    Evidence-based recommendations on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.

    Antimicrobial resistance guidance
    Published
    17 August 2022
    View recommendations

    Sections for AMR2

  31. Extracorporeal albumin dialysis for acute liver failure (HTG202)

    Evidence-based recommendations on extracorporeal albumin dialysis for acute liver failure. This involves using a dialysis machine to remove both water-soluble toxins and toxins that are attached to albumin and accumulate in liver failure.

    HealthTech guidance
    Published
    23 September 2009
    View recommendations

    Sections for HTG202

  32. Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis (ES35)

    Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis

    Evidence summary
    Published
    24 February 2021

  33. Image-guided percutaneous laser ablation for primary and secondary liver tumours (HTG722)

    Evidence-based recommendations on image-guided percutaneous laser ablation for primary and secondary liver tumours. This involves heating up liver tissue to destroy tumours.

    HealthTech guidance
    Published
    16 May 2024
    View recommendations

    Sections for HTG722

  34. Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (AMR1)

    Evidence-based recommendations on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.

    Antimicrobial resistance guidance
    Published
    17 August 2022
    View recommendations

    Sections for AMR1

  35. Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)

    Summary of the evidence on eravacycline for complicated intra-abdominal infections in adults

    Evidence summary
    Published
    11 May 2022

  36. NICE considered that more research is needed to establish the treatment sequence for vemurafenib and ipilimumab in patients who have BRAF V600 mutation-positive melanoma.

    Question NICE considered that more research is needed to establish the treatment sequence for vemurafenib and ipilimumab in patients who...

    Research recommendation
    Published
    9 June 2015

  37. Transcranial magnetic stimulation for treating and preventing migraine (HTG330)

    Evidence-based recommendations on transcranial magnetic stimulation for treating and preventing migraine. This involves placing a handheld device on the scalp to deliver magnetic pulses to the head.

    HealthTech guidance
    Published
    23 January 2014
    View recommendations

    Sections for HTG330

  38. Extracorporeal shockwave therapy for Achilles tendinopathy (HTG426)

    Evidence-based recommendations on extracorporeal shockwave therapy for treating Achilles tendinopathy in adults. This involves passing shockwaves through the skin to the affected area.

    HealthTech guidance
    Published
    21 December 2016
    View recommendations

    Sections for HTG426

  39. Hip fracture: management (CG124)

    This guideline covers managing hip fracture in adults. It aims to improve care from the time people aged 18 and over are admitted to hospital through to when they return to the community. Recommendations emphasise the importance of early surgery and coordinating care through a multidisciplinary Hip Fracture Programme to help people recover faster and regain their mobility.

    Clinical guideline
    Last updated
    6 January 2023
    View recommendations

    Sections for CG124

  40. Chronic anal fissure: botulinum toxin type A injection (ESUOM14)

    Summary of the evidence on botulinum toxin type A injection for treating chronic anal fissure to inform local NHS planning and decision-making

    Evidence summary
    Published
    25 June 2013

  41. Intralesional photocoagulation of subcutaneous congenital vascular disorders (HTG56)

    Evidence-based recommendations on intralesional photocoagulation of subcutaneous congenital vascular disorders. This involves inserting a laser fibre into the lesion to deliver the light deep within it.

    HealthTech guidance
    Published
    22 September 2004
    View recommendations

    Sections for HTG56

  42. Minimally invasive video-assisted thyroidectomy (HTG349)

    Evidence-based recommendations on minimally invasive video-assisted thyroidectomy. This involves inserting instruments through a small cut (keyhole surgery) to remove part or all of the gland.

    HealthTech guidance
    Published
    23 August 2014
    View recommendations

    Sections for HTG349

  43. Bronchial thermoplasty for severe asthma (HTG494)

    Evidence-based recommendations on bronchial thermoplasty for severe asthma in adults. This involves applying heat to the inside walls of the airways.

    HealthTech guidance
    Published
    19 December 2018
    View recommendations

    Sections for HTG494

  44. Information and support: How does each step in the care pathway for prevention and treatment of early-onset neonatal infection impact on babies and their families?

    and support: How does each step in the care pathway for prevention and treatment of early-onset neonatal infection impact on babies and...

    Research recommendation
    Published
    6 August 2021

  45. NICE encourages further research into percutaneous electrothermal treatment of the intervertebral disc  annulus. Further research should document details of patient selection, including the duration of their symptoms. It should report precise details of the technique used for treatment. Outcome measures should include pain relief and quality of life. Long-term follow-up data should include details of any subsequent procedures.

    NICE encourages further research into percutaneous electrothermal treatment of the intervertebral disc annulus. Further research should...

    Research recommendation
    Published
    15 March 2016

  46. Percutaneous laser therapy for fetal tumours (HTG118)

    Evidence-based recommendations on percutaneous laser therapy for fetal tumours. This involves inserting a needle through the mother's abdomen to the tumour and using laser energy to shrink it.

    HealthTech guidance
    Published
    28 June 2006
    View recommendations

    Sections for HTG118

  47. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19? Any explanatory notes(if applicable)...

    Research recommendation
    Published
    10 August 2021

  48. Skin involvement in systemic sclerosis: rituximab (ES7)

    Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making

    Evidence summary
    Published
    7 March 2017

  49. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG545)

    Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.

    HealthTech guidance
    Published
    24 June 2020
    View recommendations

    Sections for HTG545

  50. Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer (HTG499)

    Evidence-based recommendations on electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer in adults. This involves using a small electrical current to improve the effect of chemotherapy given directly into the bladder.

    HealthTech guidance
    Published
    30 January 2019
    View recommendations

    Sections for HTG499